Clinical Trial Update: Study Of Letrozole With Or Without Palbociclib (PD-0332991) For The First-Line Treatment Of Hormone-Receptor Positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating letrozole with or without palbociclib as first-line treatment for HR-positive advanced breast cancer completed, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Letrozole (letrozole)
• Palbociclib (palbociclib)

Snippet

Sponsor: Pfizer | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-03-19